Revenue for IDEXX Laboratories (IDXX)
According to IDEXX Laboratories's latest reported financial statements, the company's current revenue (TTM) is $4.30B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$4.30B
YoY change
+10.4%
5Y CAGR
+9.7%
Peak year (2025)
$4.30B
Cumulative revenue
$45.85B
Revenue history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Revenue history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $4.30B | +10.4% | ||
| 2024 | $3.90B | +6.5% | ||
| 2023 | $3.66B | +8.7% | ||
| 2022 | $3.37B | +4.7% | ||
| 2021 | $3.22B | +18.8% | ||
| 2020 | $2.71B | +12.5% | ||
| 2019 | $2.41B | +8.8% | ||
| 2018 | $2.21B | +12.4% | ||
| 2017 | $1.97B | +10.9% | ||
| 2016 | $1.78B | +10.8% | ||
| 2015 | $1.60B | +7.8% | ||
| 2014 | $1.49B | +7.9% | ||
| 2013 | $1.38B | +6.5% | ||
| 2012 | $1.29B | +6.1% | ||
| 2011 | $1.22B | +10.4% | ||
| 2010 | $1.10B | +7.0% | ||
| 2009 | $1.03B | +0.7% | ||
| 2008 | $1.02B | +11.0% | ||
| 2007 | $922.55M | +24.8% | ||
| 2006 | $739.12M | +15.8% | ||
| 2005 | $638.10M | +16.2% | ||
| 2004 | $549.18M | +15.4% | ||
| 2003 | $475.99M | +15.3% | ||
| 2002 | $412.67M | +6.9% | ||
| 2001 | $386.08M | +5.1% | ||
| 2000 | $367.43M | +3.2% | ||
| 1999 | $356.20M | +11.3% | ||
| 1998 | $319.90M | +21.6% | ||
| 1997 | $263.00M | -1.8% | ||
| 1996 | $267.70M | +41.9% | ||
| 1995 | $188.60M | +49.2% | ||
| 1994 | $126.40M | +35.8% | ||
| 1993 | $93.10M | +61.4% | ||
| 1992 | $57.70M | +89.2% | ||
| 1991 | $30.50M | — |
Revenue values are taken from IDEXX Laboratories's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual revenue for IDEXX Laboratories (IDXX) came in at $4.30B – grew 10.4% year-over-year.
IDEXX Laboratories revenue has grown for 28 consecutive years, with a +9.7% compound annual growth rate over 2020–2025 (5 years).
Across the available history, revenue reached its high of $4.30B in 2025 and its low of $30.50M in 1991.
IDEXX Laboratories (IDXX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $65.09B.
IDEXX Laboratories Revenue by Year
IDEXX Laboratories Revenue 2025: $4.30B
IDEXX Laboratories revenue in 2025 was $4.30B, grew 10.4% from 2024. This figure represents the highest annual value in the available history.
IDEXX Laboratories Revenue 2024: $3.90B
IDEXX Laboratories revenue in 2024 was $3.90B, grew 6.5% from 2023.
IDEXX Laboratories Revenue 2023: $3.66B
IDEXX Laboratories revenue in 2023 was $3.66B, grew 8.7% from 2022.
IDEXX Laboratories Revenue 2022: $3.37B
IDEXX Laboratories revenue in 2022 was $3.37B, edged up 4.7% from 2021.
IDEXX Laboratories Revenue 2021: $3.22B
IDEXX Laboratories revenue in 2021 was $3.22B.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers — Revenue
Companies in the same sector as IDEXX Laboratories, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Johnson & Johnson (JNJ) | $94.19B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is IDEXX Laboratories's revenue?
- Latest reported revenue for IDEXX Laboratories (IDXX) is $4.30B (period ending December 31, 2025).
How has IDEXX Laboratories revenue changed year-over-year?
- IDEXX Laboratories (IDXX) revenue changed +10.4% year-over-year on the latest annual filing.
What is the long-term growth rate of IDEXX Laboratories revenue?
- IDEXX Laboratories (IDXX) revenue compound annual growth rate is +9.7% over the most recent 5 years available.
When did IDEXX Laboratories revenue hit its highest annual value?
- IDEXX Laboratories revenue reached its highest annual value of $4.30B in 2025.
What was IDEXX Laboratories revenue in 2024?
- IDEXX Laboratories (IDXX) revenue in 2024 was $3.90B.
What was IDEXX Laboratories revenue in 2025?
- IDEXX Laboratories (IDXX) revenue in 2025 was $4.30B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
IDXX Overview
Company profile, financial tools, and key metrics
IDXX Revenue Counter
Earns $136.47 every second. See per minute, hour, and day.
IDXX Earnings Counter
Earns $33.60 per second net profit. See per minute, hour, and day.
IDXX Economic Scale
Exceeds Aruba's GDP. Compare with world economies.
IDXX What If Invested
What if you had invested $1,000? See historical returns from any date.
IDXX How It Makes Money
Discover visual breakdown of $4.30B in revenue — where it comes from and where it goes.
IDXX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
IDXX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
IDXX Daily Price Character
Explosive · 50.9% historical win rate (green days). Streaks & record days.
IDXX Buybacks
2.25% TTM buyback yield. Shareholder yield & SBC comparison.
IDXX Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.